Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
BioArctic ABs publ Nasdaq Stockholm BIOA B partner Eisai announced today that the launch of Leqembi in the EU started in Austria on August and will be launched in Germany on September
Eisai Co Ltdand Biogen Inc Nasdaq BIIB Corporate headquarters Cambridge Massachusetts CEO Christopher A Viehbacher Biogen announced today that the antiamyloid beta A monoclonal
DATROWAY datopotamab deruxtecan has been approved in China for the treatment of adult patients with unresectable or metastatic hormone receptor HR positive HER negative IHC IHC or IHC ISH
Hyloris Pharmaceuticals SA Hyloris EBR HYL a specialty biopharma company committed to addressing unmet medical needs through reinventing existing medications today announces that an exclusive license and supply agreement has been signed with Huons Co
SK bioscience a global innovative vaccine and biotech company committed to promoting human health from prevention to cure today announced that the company held an exclusive meeting with the Gates Foundation in line with the visit of Bill Gates
Andelyn Biosciences Inc a leading and patientfocused cell and gene therapy Contract Development and Manufacturing Organization CDMO has partnered with Amplo Biotechnology a pioneer in adenoassociated
SMSbiotech a San Diegobased leader in regenerative medicine today announced the initiation of its firstinhuman Phase clinical trial for Chronic Obstructive Pulmonary Disease COPD
Thermo Fisher Scientific Inc the world leader in serving science today announced the grand opening of its innovative manufacturing center of excellence facility in Mebane NC The new squarefoot carbon neutral
Regeneron Pharmaceuticals Inctoday announced that the US Food and Drug Administration FDA has extended the target action dates to the fourth quarter of for two EYLEA HD aflibercept Injection mg regulatory submissions
Somiteai a company pioneering foundation models for human stem cells today announced a strategic investment from AMD Ventures following Somites M Series A closing led by Khosla Ventures in May
